COVID-19 Endocrinopathy with Hindsight from SARS.

This article summarizes the impact of SARS-CoV and SARS-CoV-2 on the endocrine system to facilitate our understanding of the nature of coronavirus-associated endocrinopathy. Although new data are rapidly accumulating on this novel infection, many of the endocrine manifestations of COVID-19 remain incompletely elucidated. We hereby summarize various endocrine dysfunctions including coronavirus-induced new onset diabetes mellitus, hypocortisolism, thyroid hormone and reproductive system aberrations so that clinicians armed with such insights can potentially benefit COVID-19 patients at the bedside.
PMID: 33236920 [PubMed - as supplied by publisher]

Source: American Journal of Physiology. Endocrinology and Metabolism - November 25, 2020 Category: Physiology Authors: Kothandaraman N, Anantharaj R, Xue B, Yew WS, Velan SS, Karnani N, Leow MK Tags: Am J Physiol Endocrinol Metab Source Type: research